Select Medical (NYSE:SEM) Stock Rating Upgraded by StockNews.com

Select Medical (NYSE:SEM) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday.

Other equities analysts have also issued research reports about the company. UBS Group decreased their price target on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. Royal Bank of Canada upped their target price on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Finally, Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, November 25th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $39.50.

Select Medical Stock Up 0.6 %

Shares of NYSE:SEM opened at $18.75 on Tuesday. Select Medical has a 52-week low of $18.02 and a 52-week high of $40.98. The stock has a market cap of $2.43 billion, a P/E ratio of 8.76, a PEG ratio of 0.39 and a beta of 1.45. The business has a fifty day moving average of $26.34 and a two-hundred day moving average of $31.97. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. Select Medical’s quarterly revenue was up 5.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.46 earnings per share. On average, research analysts expect that Select Medical will post 1.97 earnings per share for the current year.

Insider Activity

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the sale, the vice president now directly owns 30,356 shares in the company, valued at approximately $605,602.20. This trade represents a 14.12 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the business’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the transaction, the director now directly owns 22,000 shares of the company’s stock, valued at $463,980. The trade was a 59.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 19.14% of the company’s stock.

Institutional Trading of Select Medical

Hedge funds have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP boosted its position in shares of Select Medical by 2.2% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,498,772 shares of the health services provider’s stock worth $157,728,000 after acquiring an additional 95,578 shares in the last quarter. Geode Capital Management LLC increased its stake in Select Medical by 2.0% in the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after purchasing an additional 46,880 shares during the last quarter. Principal Financial Group Inc. raised its holdings in Select Medical by 6.7% during the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock worth $82,208,000 after purchasing an additional 147,032 shares in the last quarter. Point72 Asset Management L.P. lifted its position in shares of Select Medical by 144.2% during the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after buying an additional 1,216,263 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Select Medical by 1.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock valued at $57,407,000 after buying an additional 24,439 shares in the last quarter. Institutional investors and hedge funds own 89.48% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.